Susquehanna International Group
CCEL icon

Susquehanna International Group’s Cryo-Cell International CCEL Stock Holding History

Susquehanna International Group’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.6K Sell
10,018
-2,235
-18% -$7.44K ﹤0.01% 12720
2025
Q4 		$42.1K Buy
12,253
+1,191
+11% +$4.95K ﹤0.01% 11810
2025
Q3 		$51.3K Buy
+11,062
New +$52.5K ﹤0.01% 11852

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return

Susquehanna International Group's CCEL Position: Q1 2026 in Review

Susquehanna International Group reduced its Cryo-Cell International (CCEL) stake by 18% in Q1 2026, selling an estimated $7.44K and leaving 10,018 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12720.

Susquehanna International Group first reported a position in CCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $51.3K in Q3 2025. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Susquehanna International Group held 10,018 shares of Cryo-Cell International worth $35.6K as of Q1 2026.
  • Susquehanna International Group sold 2,235 Cryo-Cell International shares in Q1 2026, an estimated $7.44K.
  • Cryo-Cell International made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12720 holding.
  • Susquehanna International Group first reported a position in Cryo-Cell International in Q3 2025 and has held it in 3 quarters since.
  • Susquehanna International Group's Cryo-Cell International position peaked at $51.3K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.